In recent years, evidence from several laboratories has indicated that various subsets of systemic lupus erythematosus exist. Some of these subsets have distinctive mucocutaneous features but more importantly they have different prevalence of renal disease—thus different prognosis. These subsets are defined by the specificity of the serum antibodies the SLE patient possesses
among subsets of human T cells exists in patients with systemic lupus erythematosus (SLE), we analyz...
Background: Previous studies and own clinical observations of patients with systemic lupus erythemat...
Background: Previous studies and own clinical observations of patients with systemic lupus erythemat...
In recent years, evidence from several laboratories has indicated that various subsets of systemic l...
In search of markers of disease activity in patients with SLE we have investigated blood lym-phocyte...
Lupus nephritis, which has various histological patterns and variable clinical outcomes, is one of t...
sus patients having antibodies to Ro and/or La, two major groups were distinguished by titration of ...
Systemic lupus erythematosus (SLE) is a heterogeneous disease with respect to disease severity, resp...
Abstract Systemic lupus erythematosus (SLE) is a clinically heterogeneous disease, which is autoimmu...
Objective: The heterogeneity of systemic lupus erythematosus (SLE) constitutes clinical and therapeu...
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with extremely heterogeneous clin...
Objective: Since characterization of the extent to which particular combinations of autoimmune disea...
Background. IgG subclasses of autoantibodies differ in their potential to induce an inflammatory res...
Systemic Lupus Erythematosus (SLE) shows a spectrum of clinical manifestations that complicate its d...
Purpose. This study evaluates high-throughput autoantibody screening and determines associated syste...
among subsets of human T cells exists in patients with systemic lupus erythematosus (SLE), we analyz...
Background: Previous studies and own clinical observations of patients with systemic lupus erythemat...
Background: Previous studies and own clinical observations of patients with systemic lupus erythemat...
In recent years, evidence from several laboratories has indicated that various subsets of systemic l...
In search of markers of disease activity in patients with SLE we have investigated blood lym-phocyte...
Lupus nephritis, which has various histological patterns and variable clinical outcomes, is one of t...
sus patients having antibodies to Ro and/or La, two major groups were distinguished by titration of ...
Systemic lupus erythematosus (SLE) is a heterogeneous disease with respect to disease severity, resp...
Abstract Systemic lupus erythematosus (SLE) is a clinically heterogeneous disease, which is autoimmu...
Objective: The heterogeneity of systemic lupus erythematosus (SLE) constitutes clinical and therapeu...
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with extremely heterogeneous clin...
Objective: Since characterization of the extent to which particular combinations of autoimmune disea...
Background. IgG subclasses of autoantibodies differ in their potential to induce an inflammatory res...
Systemic Lupus Erythematosus (SLE) shows a spectrum of clinical manifestations that complicate its d...
Purpose. This study evaluates high-throughput autoantibody screening and determines associated syste...
among subsets of human T cells exists in patients with systemic lupus erythematosus (SLE), we analyz...
Background: Previous studies and own clinical observations of patients with systemic lupus erythemat...
Background: Previous studies and own clinical observations of patients with systemic lupus erythemat...